Replies to post #107952 on Biotech Values

[DewDiligence]

Low-volume Copaxone—I expect the 1/1/11 PDUFA date will be extended to allow the FDA to review the newly submitted data.

I'm not going to post the rest of the details and comments as I don't wish to provoke more anti Teva and anti Israeli discussions. I think we already had too much of those on this board.

Please post the rest of what you wanted to post. The objectionable comments you refer to have already been removed from the board. Regards, Dew

[oldberkeley]

Genisi- I do think Marth's kibbutznik phrase was humorous, but no big deal, you're certainly correct that he was referring to Teva's well-known frugality. I'm the last person one would ever accuse of being anti-Israel, and in reviewing my posts I don't see that and I hope you didn't get that impression.

I agree that the subject has been covered. Best of luck.